Possible role of growth hormone in vascular complications of diabetes
Canivet, J.
Journees Annuelles de Diabetologie de l'Hotel-Dieu 1978: 217-225
1978
ISSN/ISBN: 0075-4439 PMID: 651098 Document Number: 126911
Document emailed within 1 workday
Related Documents
Sokolov, E.I.; Baluda, M.V.; Novikova, I.V.; Balabolkin, M.I.; Beloshitskaia, N.I. 1989: Antithrombogenic activity of the vascular wall in patients with diabetes mellitus and its role in the development of vascular complications Kardiologiia 29(6): 112-114Ermakova, N.A.; Syrodeeva, O.N.; Antsiferov, M.B.; Balatskaia, N.V.; Krasnova, L.B. 2008: Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus Vestnik Oftalmologii 124(1): 25-28
Butenandt, O.; Kiess, W. 1987: Growth hormone secretion following administration of growth hormone releasing hormone in constitutional short stature and idiopathic growth hormone deficiency Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(2): 114-115
Giusti, M.; Marini, G.; Sessarego, P.; Peluffo, F.; Valenti, S.; Caratti, C.; Giordano, G. 1991: Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone Recenti Progressi in Medicina 82(12): 665-668
Szmit-Domagalska, J.; Petriczko, E.żb.; Drozdzynska, M.; Adler, G.; Horodnicka-Jozwa, A.; Ciechanowicz, A.; Walczak, M.ła. 2016: The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland Neuro Endocrinology Letters 37(4): 282-288
Leelawattana, R.; Pratipanawatr, T.; Bunnag, P.; Kosachunhanun, N.; Suwanwalaikorn, S.; Krittiyawong, S.; Chetthakul, T.; Plengvidhya, N.; Benjasuratwong, Y.; Deerochanawong, C.; Mongkolsomlit, S.; Ngarmukos, C.; Rawdaree, P. 2006: Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes Journal of the Medical Association of Thailand 89(Suppl 1): S54-S59
Kokoszko, A.; Lewiński, A.; Karbownik-Lewińska, M.łg. 2008: The role of growth hormone and insulin-like growth factor i in oxidative processes Endokrynologia Polska 59(6): 496-501
Lamberts, S.W. 1991: Somatostatin analogs: their role in the treatment of growth hormone hypersecretion and excessive body growth Growth Regulation 1(1): 3-10
Drent, M.L.; Delemarre-van de Waal, H.A.; Wit, J.M. 2002: Once growth hormone, always growth hormone? Transition from growth hormone therapy in childhood to adulthood Nederlands Tijdschrift Voor Geneeskunde 146(4): 154-157
Snajderová, M.; Lebl, J.; Zemková, D.; Kolousková, S.; Pechová, M. 1994: Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog Ceskoslovenska Pediatrie 49(1): 25-28
1981: A study of the vascular complications of diabetes Zhonghua Nei Ke Za Zhi 20(9): 518-522
Terrasse, J.; Moinade, S.; Gentou, C.; Marre, L. 1976: Glycoproteins and the vascular complications of diabetes La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 52(12): 739-744
Yasunari, K.; Kohno, M.; Yoshikawa, J. 1999: Pathophysiology of vascular complications in diabetes Nihon Rinsho. Japanese Journal of Clinical Medicine 57(7): 1642-1647
Cuttica, C.M.; Sessarego, P.; Ponzani, P.; Falivene, M.R.; Valenti, S.; De Martini, D.; Giusti, M. 1997: Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly Recenti Progressi in Medicina 88(6): 264-268
Sarno-Moraes, C.R.; Czepielewski, M.A.; Vieira, J.G.; Chacra, A.R.; Lengyel, A.M. 1991: Inhibitory effect of calcitonin on growth hormone response to growth hormone releasing hormone in acromegaly Brazilian Journal of Medical and Biological Research 24(10): 1003-1009
Bell, J.J.; Dana, K. 1998: Lack of correlation between growth hormone provocative test results and subsequent growth rates during growth hormone therapy Pediatrics 102(2 Pt 3): 518-520
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Chen, Y.D.; Shu, S.G.; Chi, C.S. 2001: Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone Acta Paediatrica Taiwanica 42(5): 291-296
Gómez Sáez, J.M.; Fernández-Real, J.M.; Navarro, M.A.; Martinez-Matos, J.A.; Soler, J. 1993: Impaired growth hormone response to growth hormone releasing hormone in myotonic dystrophy Recenti Progressi in Medicina 84(7-8): 531-533